AUPH vs. JNJ

Last updated Jun 13, 2026

AUPH (Aurinia Pharmaceuticals Inc.) and JNJ (Johnson & Johnson) are both stocks. Both are in the Healthcare sector — AUPH in Biotechnology, JNJ in Drug Manufacturers - General. Over the past 10 years, AUPH returned 18.49%/yr vs 10.46%/yr for JNJ. At a 0.11 correlation, their price movements are largely independent.

Performance

AUPH vs. JNJ - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Aurinia Pharmaceuticals Inc. (AUPH) and Johnson & Johnson (JNJ). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, AUPH achieves a -0.82% return, which is significantly lower than JNJ's 17.68% return. Over the past 10 years, AUPH has outperformed JNJ with an annualized return of 18.49%, while JNJ has yielded a comparatively lower 10.46% annualized return.

AUPH

• 1D: -0.19%
• 1M: -1.31%
• YTD: -0.82%
• 6M: -0.19%
• 1Y: 92.22%
• 3Y*: 16.72%
• 5Y*: 4.23%
• 10Y*: 18.49%

JNJ

• 1D: 1.07%
• 1M: 5.14%
• YTD: 17.68%
• 6M: 15.11%
• 1Y: 57.60%
• 3Y*: 17.82%
• 5Y*: 10.94%
• 10Y*: 10.46%

*Multi-year figures are annualized to reflect compound growth (CAGR)

AUPH vs. JNJ - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
AUPH Aurinia Pharmaceuticals Inc.	-0.82%	77.62%	-0.11%	108.10%	-81.11%	65.37%	-31.74%	197.07%	50.55%	115.71%
JNJ Johnson & Johnson	17.68%	47.48%	-4.81%	-8.58%	5.97%	11.44%	10.82%	16.22%	-5.13%	24.43%

Correlation

The correlation between AUPH and JNJ is 0.12, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.12
Correlation (3Y) Calculated over the trailing 3-year period	0.11
Correlation (5Y) Calculated over the trailing 5-year period	0.10
Correlation (10Y) Calculated over the trailing 10-year period	0.11
Correlation (All Time) Calculated using the full available price history since Sep 3, 2014	0.11

Fundamentals

Market Cap AUPH : $2.18B JNJ : $588.98B
EPS AUPH : $2.15 JNJ : $8.65
PE Ratio AUPH : 7.37 JNJ : 27.85
PEG Ratio AUPH : 0.00 JNJ : 0.93
PS Ratio AUPH : 7.37 JNJ : 6.08
PB Ratio AUPH : 3.84 JNJ : 7.25
Total Revenue (TTM) AUPH : $298.30M JNJ : $96.36B
Gross Profit (TTM) AUPH : $267.70M JNJ : $66.60B
EBITDA (TTM) AUPH : $153.45M JNJ : $31.62B

Return for Risk

AUPH vs. JNJ — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

AUPH

AUPH Risk / Return Rank: 90
AUPH Sharpe Ratio Rank: 90
AUPH Sortino Ratio Rank: 86
AUPH Omega Ratio Rank: 88
AUPH Calmar Ratio Rank: 94
AUPH Martin Ratio Rank: 92

JNJ

JNJ Risk / Return Rank: 96
JNJ Sharpe Ratio Rank: 97
JNJ Sortino Ratio Rank: 98
JNJ Omega Ratio Rank: 97
JNJ Calmar Ratio Rank: 93
JNJ Martin Ratio Rank: 94

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

AUPH vs. JNJ - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Aurinia Pharmaceuticals Inc. (AUPH) and Johnson & Johnson (JNJ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	AUPH	JNJ	Difference
Sharpe ratio: Return per unit of total volatility	2.04	3.42	-1.38
Sortino ratio: Return per unit of downside risk	2.63	4.94	-2.31
Omega ratio: Gain probability vs. loss probability	1.38	1.61	-0.23
Calmar ratio: Return relative to maximum drawdown	5.83	5.28	+0.55
Martin ratio: Return relative to average drawdown	12.68	15.52	-2.84

AUPH vs. JNJ - Sharpe Ratio Comparison

The current AUPH Sharpe Ratio is 2.04, which is lower than the JNJ Sharpe Ratio of 3.42. The chart below compares the historical Sharpe Ratios of AUPH and JNJ, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

AUPH vs. JNJ - Drawdown Comparison

The maximum AUPH drawdown since its inception was -87.58%, which is greater than JNJ's maximum drawdown of -50.67%. Use the drawdown chart below to compare losses from any high point for AUPH and JNJ.

Drawdown Indicators

	AUPH	JNJ	Difference
Max Drawdown Largest peak-to-trough decline	-87.58%	-50.67%	-36.91%
Max Drawdown (1Y) Largest decline over 1 year	-15.91%	-10.96%	-4.95%
Max Drawdown (3Y) Largest decline over 3 years	-60.80%	-15.95%	-44.85%
Max Drawdown (5Y) Largest decline over 5 years	-87.58%	-18.41%	-69.17%
Max Drawdown (10Y) Largest decline over 10 years	-87.58%	-27.37%	-60.21%
Current Drawdown Current decline from peak	-52.18%	-2.54%	-49.64%
Average Drawdown Average peak-to-trough decline	-49.21%	-11.90%	-37.31%
Ulcer Index Depth and duration of drawdowns from previous peaks	7.30%	3.72%	+3.58%

Volatility

AUPH vs. JNJ - Volatility Comparison

Aurinia Pharmaceuticals Inc. (AUPH) has a higher volatility of 9.07% compared to Johnson & Johnson (JNJ) at 5.47%. This indicates that AUPH's price experiences larger fluctuations and is considered to be riskier than JNJ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	AUPH	JNJ	Difference
Volatility (1M) Calculated over the trailing 1-month period	9.07%	5.47%	+3.60%
Volatility (6M) Calculated over the trailing 6-month period	23.92%	12.16%	+11.76%
Volatility (1Y) Calculated over the trailing 1-year period	45.50%	16.94%	+28.56%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	67.46%	16.87%	+50.59%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	73.95%	18.48%	+55.47%

Dividends

AUPH vs. JNJ - Dividend Comparison

AUPH has not paid dividends to shareholders, while JNJ's dividend yield for the trailing twelve months is around 2.18%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
AUPH Aurinia Pharmaceuticals Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
JNJ Johnson & Johnson	2.18%	2.48%	3.40%	3.00%	2.52%	2.45%	2.53%	2.57%	2.74%	2.38%	2.73%	2.87%

Financials

AUPH vs. JNJ - Profitability Comparison

The chart below illustrates the profitability comparison between Aurinia Pharmaceuticals Inc. and Johnson & Johnson over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

AUPH - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Aurinia Pharmaceuticals Inc. reported a gross profit of 71.20M and revenue of 77.71M. Therefore, the gross margin over that period was 91.6%.

JNJ - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Johnson & Johnson reported a gross profit of 17.20B and revenue of 24.06B. Therefore, the gross margin over that period was 71.5%.

AUPH - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Aurinia Pharmaceuticals Inc. reported an operating income of 41.42M and revenue of 77.71M, resulting in an operating margin of 53.3%.

JNJ - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Johnson & Johnson reported an operating income of 6.40B and revenue of 24.06B, resulting in an operating margin of 26.6%.

AUPH - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Aurinia Pharmaceuticals Inc. reported a net income of 34.36M and revenue of 77.71M, resulting in a net margin of 44.2%.

JNJ - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Johnson & Johnson reported a net income of 5.24B and revenue of 24.06B, resulting in a net margin of 21.8%.

Frequently Asked Questions

Can I hold both AUPH and JNJ in my portfolio?

AUPH and JNJ have a correlation of 0.12, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, AUPH or JNJ?

AUPH has higher volatility (9.07%) compared to JNJ (5.47%). In terms of maximum drawdown, AUPH dropped -87.58% vs JNJ's -50.67%.

Which has better risk-adjusted returns?

JNJ currently has the higher Sharpe Ratio (3.42 vs 2.04), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.